Gender

Male: 35 (49%)

Female: 36 (51%)

Median age at surgical treatment

48 y (5 - 83 y)

Median follow-up period

7.1 y (0.2 - 17.4 y)

Stage

Stage I: 17 (24%)

Stage II: 21 (30%)

Stage III: 33 (47%)